Japan Pharmaceutical Wholesalers Association

What Japan Pharmaceutical Wholesalers Association does

Japan Pharmaceutical Wholesalers Association (JPWA, 一般社団法人日本医薬品卸売業連合会) is a Tokyo-based General Incorporated Association founded in 1941 that serves as the collective voice of Japan's pharmaceutical wholesale industry. The association's regular members are the major pharmaceutical wholesale distribution companies operating in Japan; supporting members include adjacent industry participants. JPWA's core functions are industry coordination, regulatory advocacy, compliance training, and knowledge dissemination. It engages directly with MHLW (Ministry of Health, Labour and Welfare), PMDA (Pharmaceuticals and Medical Devices Agency), the Central Social Insurance Medical Council (中医協), and the Distribution Improvement Council (流通改善懇談会), and represents Japan internationally within IFPW (International Federation of Pharmaceutical Wholesalers).

JPWA's core outputs are publications, seminars, and strategic initiatives rather than commercial products. Publications include the monthly industry journal 月刊卸薬業 (Monthly Pharmaceutical Wholesale Journal), the annual Pharmaceutical Wholesale Business Conditions Report (in data and commentary editions), the annual Japan Pharmaceutical Wholesale Company Directory, multi-volume International Committee Reports, the JGSP Good Wholesaler Practice guidelines, and ESG Case Collections. Educational programs include the annual Hilltop Seminar (ヒルトップ・セミナー), JPWA Seminars, Antitrust Law Training (since 2002), and the Self-Care Wholesale Seminar. Strategic initiatives include the WE MOVE. positioning campaign (reframing pharmaceutical wholesalers as a broader pharmaceutical distribution industry), the Self-Medication Promotion Vision (June 2024), and the DX Promotion Committee's digital transformation activity reports.

The association generates revenue through membership fees from regular and supporting members, sales of publications and directories (priced on a member/supporting-member/non-member tier, e.g., ¥27,000 vs ¥45,000 for the business conditions report data edition), annual subscriptions to the monthly journal, and fees for seminars and training programs. Distribution is direct to members and supporting members within Japan. The association does not disclose revenue publicly. As a membership organization rather than a commercial enterprise, JPWA has no traditional ownership structure; governance rests with a president and board of directors (currently President Miyata Hiromi, 宮田浩美, since 2023). JPWA's technology footprint is light: it maintains a website, social media presence, and as of September 2025 uses AI-generated voice synthesis to produce audio summaries of selected publications.

Name

Japan Pharmaceutical Wholesalers Association

Legal name

一般社团法人日本医薬品卸売業連合会

Website

https://jpwa.or.jp

Company type

Private

Founded year

1941

Operating status

Operating

Headcount range

11–50 employees

Short description

Japan Pharmaceutical Wholesalers Association (JPWA) is a Tokyo-based incorporated trade association founded in 1941 that represents Japan's pharmaceutical wholesalers, providing industry coordination, regulatory advocacy, compliance training, publications, and seminars to its member companies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Association

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Pharmaceutical wholesale
• Pharmaceutical distribution
• Industry association
• Drug pricing policy
• Supply chain compliance

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Fees: The association generates revenue through membership fees from regular members (pharmaceutical wholesale companies) and supporting members.
2. Publications and Periodicals: Revenue from publishing '月刊卸薬業' (Monthly Pharmaceutical Wholesale Journal), industry directories, and international comparison reports. Pricing varies by membership status (member vs. supporting member vs. general).
3. Seminars and Training Programs: Revenue from organizing seminars including Hilltop Seminars, JPWA Seminars, and Antitrust Law Training (独占禁止法研究会).

Pricing tiers

Distribution channels1 record

Marketing channels5 records

Core offering

JPWA is a General Incorporated Association (一般社団法人) representing pharmaceutical wholesale distributors in Japan. It provides industry coordination, regulatory advocacy, and compliance guidance through monthly industry publications, annual seminars (including the Hilltop Seminar), antitrust law training, industry directories, and policy engagement with the Ministry of Health, Labour and Welfare.

Product overview

Japan Pharmaceutical Wholesalers Association operates as a professional industry association offering a portfolio of publications, educational programs, and strategic initiatives rather than a unified product platform. The core offerings include the monthly industry magazine (月刊卸薬業), annual business condition reports (経営概況資料編・解説編), the company directory (企業名簿), and multi-volume international comparative reports. Key educational programs include the Hilltop Seminar series and Antitrust Law Training. The association also publishes the WE MOVE initiative materials, ESG case collections, JGSP (Good Wholesaler Practice) guidelines, and strategic vision documents including the Self-Medication Promotion Vision. Digital content includes AI-generated audio summaries of major publications and video materials from DX promotion activities.

Differentiator

Problem solved

Functional benefit

Brands

• WE MOVE. Initiative positioning pharmaceutical wholesalers as part of the broader medical distribution industry, symbolizing movement and transformation
• Hilltop Seminar (ヒルトップ・セミナー)
• 月刊卸薬業 (Gekkan Oroshi Gyogyou)

Products and services

• 月刊卸薬業 (Monthly Pharmaceutical Wholesaler Magazine)
• WE MOVE.
• ESG事例集 (ESG Case Collection)
• 医薬卸連ガイド (JPWA Guide)
• 日本医薬品卸企業名簿 (Japan Pharmaceutical Wholesale Company Directory)
• 医薬品卸売業の経営概況 (Pharmaceutical Wholesale Business Conditions Report)
• 国際委員会報告書 (International Committee Reports)
• JGSP (医薬品卸売業 Guidance)
• セルフメディケーション推進ビジョン (Self-Medication Promotion Vision)
• ヒルトップ・セミナー (Hilltop Seminar)
• 日本医薬品卸売業連合会セミナー (JPWA Seminars)
• 独占禁止法研修 (Antitrust Law Training)
• デジタル・リーフレット（動画） (Digital Leaflet Video)

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Partnerships

Nine partnerships are on record, tiered major and core.

• IFPW (International Federation of Pharmaceutical Wholesalers)majorStrategic or Co-development PartnerInternational federation connecting national pharmaceutical wholesale associations globally. JPWA participates in IFPW general assemblies (Mexico 2026, Miami 2024, etc.) for international knowledge exchange and industry benchmarking.
• Ministry of Health, Labour and Welfare (厚生労働省/MHLW)coreOthersGovernment ministry overseeing pharmaceutical distribution regulation, pricing, and healthcare policy. JPWA engages through 中医協 (Central Social Insurance Medical Council),流通改善懇談会 (Distribution Improvement Council), and various committees.
• PMDA (Pharmaceuticals and Medical Devices Agency)coreOthersJapan's regulatory agency for pharmaceuticals, medical devices, and regenerative medicine. JPWA coordinates on safety, quality, and compliance matters.
• Japan Pharmaceutical Manufacturers Association (日本製薬団体連合会)majorStrategic or Co-development PartnerUmbrella organization of pharmaceutical industry groups. JPWA collaborates on distribution improvement, pricing negotiations, and supply chain issues.
• Japan Generic Pharmaceuticals Association (日本ジェネリック製薬協会)majorStrategic or Co-development PartnerIndustry association for generic pharmaceutical manufacturers. Collaborates with JPWA on generic distribution and supply chain matters.
• Japan OTC Medicines Association (日本OTC医薬品協会)majorStrategic or Co-development PartnerSelf-medication products association. JPWA operates OTC Wholesale Council (大衆薬卸協議会) for OTC product distribution coordination.
• Japan Medical Association (日本医師会)majorStrategic or Co-development PartnerPhysician association representing doctors. JPWA collaborates on healthcare delivery, prescription management, and pharmaceutical supply chain.
• Japan Pharmacists Association (日本涯剤師会)majorStrategic or Co-development PartnerProfessional association for pharmacists. JPWA works on dispensing pharmacy relations, prescription processing, and community pharmacy coordination.
• Japan Chamber of Pharmacy (日本保険薬局協会)majorStrategic or Co-development PartnerAssociation of health insurance pharmacies. JPWA coordinates on drug pricing negotiations, distribution improvement, and supply chain matters.

Scale indicators1 record

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Japan Pharmacists Association (日本薬剤師会): Professional association representing pharmacists that dispense JPWA members' products. Listed as a JPWA partner; comparable membership-trade-body model in the adjacent downstream segment of the same distribution chain.
• Japan Generic Pharmaceuticals Association (日本ジェネリック製薬協会): Industry association for generic pharmaceutical manufacturers. Listed as a JPWA partner for generic distribution; comparable trade-association structure serving a related pharma segment.
• Japan Pharmaceutical Manufacturers Association (JPMA / 日本製薬団体連合会): Umbrella association representing pharmaceutical manufacturer groups in Japan. Listed as a JPWA partner for distribution improvement and pricing policy — broader in scope (upstream), but an obvious peer for industry-coordination services in the same pharma value chain.

Direct peers

• Healthcare Distribution Alliance (HDA): US national trade association for pharmaceutical wholesalers and distributors. Operates the same membership-publication-advocacy model as JPWA, serves analogous members, and is the de facto US counterpart of JPWA.
• International Federation of Pharmaceutical Wholesalers (IFPW): Global federation of national pharmaceutical wholesaler associations that JPWA actively participates in (Mexico 2026, Miami 2024). It is the most directly comparable peer — JPWA is a member association, IFPW is the international federation of such associations.
• GIRP (European Healthcare Distribution Association): European umbrella body for pharmaceutical full-line wholesalers. Same trade-association model serving the same type of members across Europe; comparable role in GDP standards, advocacy, and international benchmarking.

Others

• PMDA (Pharmaceuticals and Medical Devices Agency): Japanese regulatory authority for pharmaceuticals and medical devices. Classified as 'OTHERS' because it is a regulator rather than a peer association, but is included because JPWA coordinates with PMDA on compliance, safety, and quality matters — making it the most consequential counterpart relationship.
• Ministry of Health, Labour and Welfare (MHLW / 厚生労働省): Japanese government ministry overseeing pharmaceutical distribution policy and pricing. Not a peer in the association sense, but a key counterpart — JPWA's relevance is built on its engagement with MHLW advisory bodies (中医協, 流通改善懇談会).

Regional players

• China Pharmaceutical Industry Association (CPIA): National pharmaceutical industry association in China. Comparable in function (advocacy, coordination, standards), though geographically distinct; included because JPWA produces cross-country distribution benchmarking reports that reference such peers.
• Korean Pharmaceutical Association (대한약사회): Major Korean pharmaceutical professional/industry association relevant for cross-border benchmarking given JPWA's international comparative report series covering distribution costs and pricing systems in Asian markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/WE_MOVE_meds
• Facebookfacebook.com/profile.php?id=100089385825545
• Instagraminstagram.com/we_move_official

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Japan Pharmaceutical Wholesalers Association